Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Stryker Stock Quote

Stryker (NYSE: SYK)

$338.73
(-0.1%)
-$0.40
Price as of April 16, 2024, 11:19 a.m. ET

Stryker Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
SYK +17.44% +98.90% +14.74% +79,380%
S&P +22.34% +74.52% +11.78% +2,868%

Stryker Company Info

Stryker Corp. is a medical technology company, which engages in the provision of innovative products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.

News & Analysis

The Fool has written over 300 articles on Stryker.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.